FURTHER ALLIANCE PHARMA plc INVESTMENT

LDG plc

(“LDG”) or the "Company")

Further Alliance Pharma plc Investment

LDG is pleased to announce that, further to its announcement on 22 December 2022, it has purchased an additional 18,686,042 ordinary shares in Alliance Pharma plc ("Alliance") (LON:APH), at an average price of £0.5911 per ordinary share, for a total cash consideration of £3,452,782.

Following these purchases, LDG is interested in approximately 3.46% of Alliance’s issued share capital.

Alliance is an international healthcare group founded in 1996 and headquartered in the United Kingdom. The company acquires, markets, and distributes consumer healthcare and prescription medicine products.

For the year ended 31 December 2021, Alliance reported an underlying pre-tax profit of £42.2 million. As at 30 June 2022, Alliance reported net assets of £296.9 million.

Download full pdf below